SMIM12

gene
On this page

Also known as FLJ90372

Summary

SMIM12 (small integral membrane protein 12, HGNC:25154) is a protein-coding gene on chromosome 1p34.3, encoding Small integral membrane protein 12 (Q96EX1).

Located in mitochondrion.

Source: NCBI Gene 113444 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 14 total
  • MANE Select transcript: NM_138428

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25154
Approved symbolSMIM12
Namesmall integral membrane protein 12
Location1p34.3
Locus typegene with protein product
StatusApproved
AliasesFLJ90372
Ensembl geneENSG00000163866
Ensembl biotypeprotein_coding
Entrez113444

Gene structure

Transcript identifiers

Ensembl transcripts: 21 — 20 protein_coding, 1 nonsense_mediated_decay

ENST00000417239, ENST00000423898, ENST00000426886, ENST00000446026, ENST00000456842, ENST00000521580, ENST00000910618, ENST00000910619, ENST00000910620, ENST00000940216, ENST00000940217, ENST00000940218, ENST00000940219, ENST00000940220, ENST00000940221, ENST00000952717, ENST00000952718, ENST00000952719, ENST00000952720, ENST00000952721, ENST00000952722

RefSeq mRNA: 4 — MANE Select: NM_138428 NM_001164824, NM_001164825, NM_001320261, NM_138428

CCDS: CCDS53295

Canonical transcript exons

ENST00000521580 — 2 exons

ExonStartEnd
ENSE000022432083485036234855982
ENSE000022739153485967734859749

Expression profiles

Bgee: expression breadth ubiquitous, 254 present calls, max score 95.82.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 26.4411 / max 91.6704, expressed in 1821 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1164026.44111821

Top tissues by expression

255 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ileal mucosaUBERON:000033195.82gold quality
tibialis anteriorUBERON:000138595.70gold quality
islet of LangerhansUBERON:000000693.95gold quality
right lobe of liverUBERON:000111493.93gold quality
prefrontal cortexUBERON:000045193.91gold quality
popliteal arteryUBERON:000225093.91gold quality
tibial arteryUBERON:000761093.90gold quality
left adrenal glandUBERON:000123493.89gold quality
left adrenal gland cortexUBERON:003582593.74gold quality
mucosa of transverse colonUBERON:000499193.64gold quality
endothelial cellCL:000011593.62gold quality
right adrenal glandUBERON:000123393.49gold quality
heart left ventricleUBERON:000208493.43gold quality
left coronary arteryUBERON:000162693.41gold quality
heart right ventricleUBERON:000208093.40gold quality
right adrenal gland cortexUBERON:003582793.40gold quality
cardiac ventricleUBERON:000208293.31gold quality
aortaUBERON:000094793.28gold quality
adrenal cortexUBERON:000123593.23gold quality
apex of heartUBERON:000209893.20gold quality
coronary arteryUBERON:000162193.08gold quality
gastrocnemiusUBERON:000138892.90gold quality
adrenal glandUBERON:000236992.79gold quality
right atrium auricular regionUBERON:000663192.67gold quality
right coronary arteryUBERON:000162592.60gold quality
thoracic aortaUBERON:000151592.56gold quality
heartUBERON:000094892.55gold quality
muscle of legUBERON:000138392.55gold quality
left ventricle myocardiumUBERON:000656692.55gold quality
ascending aortaUBERON:000149692.52gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.74
E-GEOD-99795no127.30

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

129 targeting SMIM12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3162-3P100.0065.37363
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-4283100.0066.422097
HSA-MIR-4673100.0066.641490
HSA-MIR-8485100.0077.574731
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-366299.9973.825684
HSA-MIR-450099.9972.722367
HSA-MIR-186-5P99.9970.833707
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-3605-5P99.9667.12932
HSA-MIR-218-5P99.9372.222103
HSA-MIR-515-5P99.9269.822343
HSA-MIR-519E-5P99.9269.622358
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-6783-3P99.8967.922059
HSA-MIR-1343-3P99.8966.781815
HSA-MIR-153-5P99.8973.866317
HSA-MIR-548D-3P99.8770.674362
HSA-MIR-30A-3P99.8769.742928
HSA-MIR-30D-3P99.8769.922917
HSA-MIR-30E-3P99.8769.682942
HSA-MIR-449299.8768.253611
HSA-MIR-548BB-3P99.8670.584354
HSA-MIR-394199.8670.542735
HSA-MIR-383-3P99.8565.841359

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriosmim12ENSDARG00000070358
mus_musculusSmim12ENSMUSG00000042380
rattus_norvegicusSmim12ENSRNOG00000014352
drosophila_melanogasterCG34228FBGN0085257

Protein

Protein identifiers

Small integral membrane protein 12Q96EX1 (reviewed: Q96EX1)

All UniProt accessions (3): E5RH51, Q96EX1, L0R6D7

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the SMIM12 family.

RefSeq proteins (4): NP_001158296, NP_001158297, NP_001307190, NP_612437* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR031933UPF0767Family

Pfam: PF15990

UniProt features (3 total): chain 1, transmembrane region 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96EX1-F177.920.29

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 76 (showing top): RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN, chr1p34, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, GSE14415_INDUCED_TREG_VS_TCONV_DN, ASH1L_TARGET_GENES, DIDO1_TARGET_GENES, DMRT1_TARGET_GENES, HOXC13_TARGET_GENES, LHX9_TARGET_GENES, NFKBIA_TARGET_GENES, SNIP1_TARGET_GENES, TEAD2_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): mitochondrion (GO:0005739), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cytoplasm1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

2451 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SMIM12SHISA4Q96DD7650
SMIM12BEND7Q8N7W2616
SMIM12LRRC40Q9H9A6555
SMIM12NAIF1Q69YI7536
SMIM12ZC3H8Q8N5P1525
SMIM12MOCS1Q9NZB8493
SMIM12LCTLQ6UWM7490
SMIM12CLEC2LP0C7M8472
SMIM12TCAIMQ8N3R3459
SMIM12MNMIP1A4FU49457
SMIM12PAMR1Q6UXH9455
SMIM12BTBD8Q5XKL5453
SMIM12TSPYL6Q8N831447
SMIM12KRT36O76013436
SMIM12LEPROTL1O95214429

IntAct

23 interactions, top by confidence:

ABTypeScore
LAMP2SMIM12psi-mi:“MI:0915”(physical association)0.560
SH3GLB1SMIM12psi-mi:“MI:0915”(physical association)0.560
PRPF40ASMIM12psi-mi:“MI:0915”(physical association)0.560
USB1TOMM5psi-mi:“MI:0914”(association)0.350
SMIM12VRK1psi-mi:“MI:0914”(association)0.350
AP3B1psi-mi:“MI:0914”(association)0.350
LETM1LETM2psi-mi:“MI:0914”(association)0.350
AIFM1NUDT19psi-mi:“MI:2364”(proximity)0.270
COX14NUDT19psi-mi:“MI:2364”(proximity)0.270
COX4I1HAX1psi-mi:“MI:2364”(proximity)0.270
SCO1HAX1psi-mi:“MI:2364”(proximity)0.270
SFXN1HAX1psi-mi:“MI:2364”(proximity)0.270
IMMP1LNUDT19psi-mi:“MI:2364”(proximity)0.270
OMA1HAX1psi-mi:“MI:2364”(proximity)0.270
PARLHAX1psi-mi:“MI:2364”(proximity)0.270
SMIM12psi-mi:“MI:0915”(physical association)0.000

BioGRID (46): SMIM12 (Affinity Capture-MS), IL36A (Affinity Capture-MS), VRK1 (Affinity Capture-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS), SMIM12 (Proximity Label-MS)

ESM2 similar proteins: A1L2P2, A1XQT2, A5PJ82, A8MTT3, D2H617, D4ACP2, E2R5I0, F6USH3, G1QDE8, G1S9B8, O95139, P04038, P09669, P0CB93, P0CB94, P11951, P80977, Q02367, Q0MQ88, Q0MQ89, Q0MQ90, Q0MQE0, Q0MQE1, Q0Q4Z0, Q28EM2, Q28GF4, Q29259, Q3UIU2, Q4I8P5, Q5BKW8, Q5RK28, Q68EV8, Q78RX3, Q7YRJ8, Q7YRJ9, Q7YRK0, Q7YRK1, Q7YRK2, Q7YRK3, Q7YRK7

Diamond homologs: A1L2P2, A5PJ82, D2H617, D4ACP2, E2R5I0, F6USH3, G1QDE8, G1S9B8, Q28EM2, Q5BKW8, Q68EV8, Q78RX3, Q96EX1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

14 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance11
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1306 predictions. Top by Δscore:

VariantEffectΔscore
1:34755193:CAGG:Cdonor_loss1.0000
1:34755195:GGTAA:Gdonor_loss1.0000
1:34755196:G:GAdonor_loss1.0000
1:34757302:TGCA:Tacceptor_loss1.0000
1:34757303:GCA:Gacceptor_loss1.0000
1:34757305:A:AGacceptor_gain1.0000
1:34757305:AGTA:Aacceptor_loss1.0000
1:34757306:G:Aacceptor_loss1.0000
1:34757306:G:GAacceptor_gain1.0000
1:34757306:GT:Gacceptor_gain1.0000
1:34757306:GTA:Gacceptor_gain1.0000
1:34757306:GTAGC:Gacceptor_gain1.0000
1:34784727:A:AGacceptor_gain1.0000
1:34784728:A:Gacceptor_gain1.0000
1:34784737:GGTA:Gacceptor_gain1.0000
1:34794191:TTGCA:Tacceptor_loss1.0000
1:34794192:TGCAG:Tacceptor_loss1.0000
1:34794193:GCA:Gacceptor_loss1.0000
1:34794194:CAGAC:Cacceptor_loss1.0000
1:34794195:A:AGacceptor_gain1.0000
1:34794195:AGAC:Aacceptor_gain1.0000
1:34794195:AGACG:Aacceptor_gain1.0000
1:34794196:G:GAacceptor_gain1.0000
1:34794196:GAC:Gacceptor_gain1.0000
1:34794196:GACG:Gacceptor_gain1.0000
1:34794196:GACGG:Gacceptor_gain1.0000
1:34855979:ACATC:Aacceptor_loss1.0000
1:34855980:CAT:Cacceptor_gain1.0000
1:34855980:CATCT:Cacceptor_loss1.0000
1:34855981:ATC:Aacceptor_loss1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000140165 (1:34857806 TG>T), RS1000298447 (1:34858272 G>A,C), RS1000412452 (1:34857981 C>G,T), RS1000492477 (1:34858069 CA>C), RS1000653466 (1:34853401 G>A), RS1001088871 (1:34859481 T>C), RS1001562824 (1:34859170 G>A,T), RS1001827638 (1:34852809 G>A,T), RS1002110504 (1:34853046 C>T), RS1002365309 (1:34858479 G>A), RS1002402381 (1:34858812 C>T), RS1002504611 (1:34856421 G>A), RS1002511145 (1:34850255 T>C), RS1002553149 (1:34849881 G>A), RS1002664294 (1:34856154 C>A,G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST009612_3Triglyceride levels x thiazide or thiazide-like diuretics use interaction6.000000e-07
GCST90002400_23Plateletcrit3.000000e-11
GCST90002401_12Platelet distribution width1.000000e-22
GCST90002401_13Platelet distribution width3.000000e-09

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004530triglyceride measurement
EFO:0007985platelet crit
EFO:0007984platelet component distribution width

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

17 total (human), top 17 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, decreases methylation, decreases expression2
Valproic Acidincreases expression, affects expression2
beta-lapachoneincreases expression1
arseniteaffects binding, increases reaction1
di-n-butylphosphoric acidaffects expression1
Fulvestrantaffects cotreatment, decreases methylation1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Dexamethasoneincreases expression1
Leadaffects expression1
Methotrexatedecreases expression1
Methyl Methanesulfonatedecreases expression1
Silverdecreases expression1
Smokedecreases expression1
Thiramdecreases expression1
Copper Sulfatedecreases expression1
Particulate Matterincreases abundance, increases expression1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D8AYUbigene A-549 SMIM12 KOCancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.